FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food …
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the …
CDC warns that RSV cases may be starting to rise | CNN
Sep 5, 2023 · The US Centers for Disease Control and Prevention is warning physicians that cases of respiratory syncytial virus, known as RSV, are rising in the Southeast — and that …
RSV Vaccines Will Carry Warning for Guillain-Barré Syndrome
4 days ago · The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days …
FDA approves Moderna’s mRNA RSV vaccine for older adults
May 31, 2024 · The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by …
Federal Officials Revise Recommendations for R.S.V. Vaccine
Jun 26, 2024 · In an unusual move, federal health officials revised their recommendations for who should receive the vaccine against the respiratory syncytial virus.
Progress at last against RSV - Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in …
FDA approves first RSV vaccine for at-risk adults in their 50s
Jun 7, 2024 · The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe …
‘A good day’: FDA approves world’s first RSV vaccine - Nature
May 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first …
RSV: What to know about the latest surge and treatments : NPR
Nov 2, 2022 · Here are answers to some of the most common questions about the RSV infection, who is most at risk and what might be causing this year's outbreak. Why might RSV be …